Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescentsChanges in behavior as side effects in methylphenidate treatment: review of the literatureImproved quality of life among adolescents with attention-deficit/hyperactivity disorder is mediated by protective factors: a cross sectional survey.Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.Psychiatric diagnoses and medication treatment among patients presenting for paediatric weight management: associations with adiposity, aerobic fitness and cardiometabolic health.Effects of Folic Acid on Appetite in Children with Attention Deficit Hyperactivity Disorder (ADHD) Treated with Methylphenidate: A Randomized Double-Blind Clinical Trial.A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.
P2860
Q22061981-8D3C1E74-18CE-4C3B-82AD-E924CC3B538AQ24186168-0E5A3D87-7FFD-40B2-85A4-A0B5B8222573Q28078623-C48FB9B6-6650-4CBA-A552-7067B737E972Q35599178-23AFA753-64C5-45D1-8969-0FC3C31A5ED9Q37667633-09114215-8CE0-4165-87F5-E9DD28E5957EQ47227409-7E1A8C64-898F-4844-8AAA-6CB68A231460Q49338753-2F82EF04-D161-41E4-B07B-DC3114250560Q50109827-225D1691-E05E-4B1F-AD72-0E1C4318E8E8
P2860
Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimizing adverse events whil ...... phetamine and methylphenidate.
@en
Minimizing adverse events whil ...... phetamine and methylphenidate.
@nl
type
label
Minimizing adverse events whil ...... phetamine and methylphenidate.
@en
Minimizing adverse events whil ...... phetamine and methylphenidate.
@nl
prefLabel
Minimizing adverse events whil ...... phetamine and methylphenidate.
@en
Minimizing adverse events whil ...... phetamine and methylphenidate.
@nl
P2860
P356
P1476
Minimizing adverse events whil ...... phetamine and methylphenidate.
@en
P2093
Bjørn E Ramtvedt
Henning S Aabech
P2860
P304
P356
10.1089/CAP.2013.0114
P577
2014-03-25T00:00:00Z